BCL2 and Merkel cell skin cancer: Previous studies have attempted the use of BCL-2 antisense oligonucleotides to silence BCL-2 in vivo with mouse models and in a phase II clinical trial; however, these investigations demonstrated very little efficacy in the treatment of MCC [94].